Syrna Therapeutics, Inc. — Form D
Syrna Therapeutics, Inc. of DEL MAR, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-10. The offering totals $10.9M, of which $10.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-10
- Form: D
- Accession: 0001989653-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.9M
- Amount sold: $10.9M
- Investors: 3
- Date of first sale: 2023-08-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-489346
Issuer
- Name: Syrna Therapeutics, Inc.
- CIK: 0001989653
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 13759 PINE NEEDLES DRIVE, DEL MAR, CA, 92014
- Phone: 858-735-1184
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Aiden Aceves | Director | Cary, NC |
| Joel Dudley | Director | New Haven, CT |
| Thomas Hermann | Director | Del Mar, CA |
| David Weitz | Director | Del Mar, CA |
| David Weitz | Executive Officer | Del Mar, CA |
More